Springer Cham, Switzerland (2025)
The AMPLITUDE-O trial, involving 4,076 patients with T2D and a history of either CVD or kidney disease, participants were randomised to receive efpeglenatide or placebo
Water remains the most effective choice, and adequate hydration should be combined with increased dietary fibre intake where tolerated
Gastrin is a neuroendocrine peptide, which acts on the cholecystokinin-2 (CCK2) receptor and is expressed in the pancreas with the rationale being that as it is involved in pancreas development, it might increase -cell mass and glycemic control [70]
In adults with obesity/overweight plus at least one comorbidity (no diabetes): 65.3% of patients on 12 mg dropped below a BMI of 30 no longer clinically obese
At this stage, GLP-1 medications cannot be viewed as treatments for endometriosis